NEOS Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7M Buy
321,866
+52,085
+19% +$3.47M 0.08% 174
2026
Q1
$16.9M Buy
269,781
+36,037
+15% +$2.51M 0.09% 180
2025
Q4
$15.5M Buy
233,744
+57,762
+33% +$3.73M 0.09% 175
2025
Q3
$11.8M Buy
175,982
+65,066
+59% +$5.15M 0.09% 181
2025
Q2
$9.68M Buy
110,916
+31,639
+40% +$2.48M 0.12% 154
2025
Q1
$5.41M Buy
79,277
+3,105
+4% +$253K 0.1% 188
2024
Q4
$5.92M Buy
76,172
+10,113
+15% +$749K 0.14% 137
2024
Q3
$4.43M Buy
66,059
+7,422
+13% +$609K 0.13% 145
2024
Q2
$6.65M Buy
58,637
+15,627
+36% +$1.98M 0.27% 68
2024
Q1
$5.97M Buy
43,010
+19,119
+80% +$2.4M 0.37% 49
2023
Q4
$2.96M Buy
23,891
+6,812
+40% +$696K 0.28% 69
2023
Q3
$1.59M Buy
+17,079
New +$1.93M 0.2% 108

Other funds holding DXCM

NEOS Investment Management's DXCM Position: Q2 2026 in Review

NEOS Investment Management increased its DexCom (DXCM) stake by 19% in Q2 2026, buying an estimated $3.47M and bringing the position to 321,866 shares worth $21.7M. The position accounts for 0.08% of the portfolio, ranked #174.

NEOS Investment Management first reported a position in DXCM in Q3 2023 and has held it in 12 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • NEOS Investment Management held 321,866 shares of DexCom worth $21.7M as of Q2 2026.
  • NEOS Investment Management bought 52,085 DexCom shares in Q2 2026, an estimated $3.47M.
  • DexCom made up 0.08% of NEOS Investment Management's portfolio in Q2 2026, its #174 holding.
  • NEOS Investment Management first reported a position in DexCom in Q3 2023 and has held it in 12 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.